Intervention Review

Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding

  1. Anne Lethaby1,*,
  2. Kirsten Duckitt2,
  3. Cindy Farquhar1

Editorial Group: Cochrane Gynaecology and Fertility Group

Published Online: 31 JAN 2013

Assessed as up-to-date: 5 JUL 2012

DOI: 10.1002/14651858.CD000400.pub3


How to Cite

Lethaby A, Duckitt K, Farquhar C. Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding. Cochrane Database of Systematic Reviews 2013, Issue 1. Art. No.: CD000400. DOI: 10.1002/14651858.CD000400.pub3.

Author Information

  1. 1

    University of Auckland, Obstetrics and Gynaecology, Auckland, New Zealand

  2. 2

    Campbell River and District General Hospital, Campbell River, British Colombia, Canada

*Anne Lethaby, Obstetrics and Gynaecology, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand. a.lethaby@auckland.ac.nz.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 31 JAN 2013

SEARCH

Options for accessing this content:

  • If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
    http://wiley.force.com/Interface/ContactJournalCustomerServices_V2.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens

or

Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.